Compare POWW & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POWW | TKNO |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Ordnance And Accessories | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.8M | 280.9M |
| IPO Year | N/A | 2021 |
| Metric | POWW | TKNO |
|---|---|---|
| Price | $2.36 | $5.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.40 | N/A |
| AVG Volume (30 Days) | ★ 691.6K | 238.2K |
| Earning Date | 02-09-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $14.56 | $8.27 |
| Revenue Next Year | $0.50 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $1.08 | $1.91 |
| 52 Week High | $2.46 | $6.68 |
| Indicator | POWW | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 74.11 | 60.64 |
| Support Level | $1.94 | $4.79 |
| Resistance Level | N/A | $5.84 |
| Average True Range (ATR) | 0.10 | 0.46 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 78.00 | 63.22 |
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.